Lymphoma News

In this video, Brian T. Hill, MD, PhD, director of the Lymphoid Malignancies Program and a staff physician at the Cleveland Clinic Cancer Institute, discusses unmet needs in the mantle cell lymphoma space.

In this video, Brian T. Hill, MD, PhD, director of the Lymphoid Malignancies Program and a staff physician at the Cleveland Clinic Cancer Institute, discusses difficulties in accessing mantle cell lymphoma care and how this can be improved. 

In this video, Brian T. Hill, MD, PhD, director of the Lymphoid Malignancies Program and a staff physician at the Cleveland Clinic Cancer Institute, discusses new and upcoming treatments for mantle cell lymphoma.

In this video, Brian T. Hill, MD, PhD, director of the Lymphoid Malignancies Program and a staff physician at the Cleveland Clinic Cancer Institute, discusses his approach for treating patients with relapsed/refractory mantle cell lymphoma.

When a patient with cancer tells their clinician they smoke, Andrea C. King, PhD, wants alarm bells to ring inside the exam room — figuratively speaking.

Individuals with cancer are at increased risk for suicide, and suicidal ideation can persist for years after diagnosis.

The U.S. Supreme Court today ruled Bayer cannot be sued over state-level claims that the company failed to warn the public about cancer risks from its popular weedkiller Roundup.

Gaps in cancer mortality based on race or ethnicity continue to narrow overall, but several specific populations still exhibit higher risk for developing or dying of the disease, according to a new report.

Patients with serious illness may gradually develop a form of “double awareness” — the ability to hold hope for continued living while also preparing for the possibility of dying.